| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 139.292 | 162.499 | 189.137 | 176.343 | 197.471 | 173.744 | 197.754 | 180.422 | 0 | 4.612 |
| Total Income - EUR | 140.519 | 162.570 | 189.309 | 176.343 | 197.471 | 174.319 | 198.104 | 188.134 | 0 | 6.681 |
| Total Expenses - EUR | 135.018 | 152.912 | 174.756 | 174.268 | 194.541 | 172.873 | 196.117 | 193.801 | 7.026 | 6.427 |
| Gross Profit/Loss - EUR | 5.501 | 9.658 | 14.552 | 2.075 | 2.930 | 1.446 | 1.986 | -5.668 | -7.026 | 255 |
| Net Profit/Loss - EUR | 4.606 | 8.036 | 10.624 | 311 | 954 | 24 | 44 | -7.979 | -7.026 | -195 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Danadi Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 62.185 | 59.084 | 71.632 | 32.860 | 60.969 | 50.766 | 38.776 | 22.076 | 19.289 | 16.786 |
| Current Assets | 66.147 | 45.667 | 47.836 | 53.478 | 35.020 | 33.352 | 39.392 | 3.968 | 1.133 | 1.628 |
| Inventories | 41.153 | 25.749 | 28.489 | 24.723 | 14.532 | 9.670 | 11.102 | 0 | 0 | 0 |
| Receivables | 17.307 | 16.535 | 11.963 | 15.713 | 15.325 | 12.085 | 20.558 | 1.747 | 1.039 | 759 |
| Cash | 7.688 | 3.384 | 7.384 | 13.042 | 5.162 | 11.598 | 7.732 | 2.221 | 93 | 869 |
| Shareholders Funds | 24.776 | 32.559 | 56.913 | 56.180 | 25.642 | 13.992 | 4.771 | -3.193 | -10.209 | -18.591 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 103.022 | 72.193 | 60.937 | 57.960 | 92.588 | 79.394 | 81.898 | 37.552 | 38.920 | 37.005 |
| Income in Advance | 534 | 0 | 1.619 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Danadi Med Srl